FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994678422> ?p ?o ?g. }

• W1994678422 abstract "There is currently no validated strategy for the timing of renal replacement therapy (RRT) for acute kidney injury (AKI) in the intensive care unit (ICU) when short-term life-threatening metabolic abnormalities are absent. No adequately powered prospective randomized study has addressed this issue to date. As a result, significant practice heterogeneity exists and may expose patients to either unnecessary hazardous procedures or undue delay in RRT.This is a multicenter, prospective, randomized, open-label parallel-group clinical trial that compares the effect of two RRT initiation strategies on overall survival of critically ill patients receiving intravenous catecholamines or invasive mechanical ventilation and presenting with AKI classification stage 3 (KDIGO 2012). In the 'early' strategy, RRT is initiated immediately. In the 'delayed' strategy, clinical and metabolic conditions are closely monitored and RRT is initiated only when one or more events (severity criteria) occur, including: oliguria or anuria for more than 72 hours after randomization, serum urea concentration >40 mmol/l, serum potassium concentration >6 mmol/l, serum potassium concentration >5.5 mmol/l persisting despite medical treatment, arterial blood pH <7.15 in a context of pure metabolic acidosis (PaCO2 < 35 mmHg) or in a context of mixed acidosis with a PaCO2 ≥ 50 mmHg without possibility of increasing alveolar ventilation, acute pulmonary edema due to fluid overload despite diuretic therapy leading to severe hypoxemia requiring oxygen flow rate >5 l/min to maintain SpO2 > 95% or FiO2 > 50% under invasive or noninvasive mechanical ventilation. The primary outcome measure is overall survival, measured from randomization (D0) until death, regardless of the cause. The minimum follow-up duration for each patient will be 60 days. Two interim analyses are planned, blinded to group allocation. It is expected that there will be 620 subjects in all.The AKIKI study will be one of the very few large randomized controlled trials evaluating mortality according to the timing of RRT in critically ill patients with AKI classification stage 3 (KDIGO 2012). Results should help clinicians decide when to initiate RRT.ClinicalTrials.gov NCT01932190." @default.
• W1994678422 created "2016-06-24" @default.
• W1994678422 creator A5003423056 @default.
• W1994678422 creator A5007115589 @default.
• W1994678422 creator A5014115470 @default.
• W1994678422 creator A5015168137 @default.
• W1994678422 creator A5020642212 @default.
• W1994678422 creator A5023154022 @default.
• W1994678422 creator A5024199696 @default.
• W1994678422 creator A5024835115 @default.
• W1994678422 creator A5025301409 @default.
• W1994678422 creator A5028936457 @default.
• W1994678422 creator A5029770659 @default.
• W1994678422 creator A5037820928 @default.
• W1994678422 creator A5042632008 @default.
• W1994678422 creator A5050403703 @default.
• W1994678422 creator A5050980807 @default.
• W1994678422 creator A5052636813 @default.
• W1994678422 creator A5053916099 @default.
• W1994678422 creator A5054873949 @default.
• W1994678422 creator A5060475199 @default.
• W1994678422 creator A5061283872 @default.
• W1994678422 creator A5063822608 @default.
• W1994678422 creator A5064736877 @default.
• W1994678422 creator A5065430036 @default.
• W1994678422 creator A5070060842 @default.
• W1994678422 creator A5071301713 @default.
• W1994678422 creator A5073088328 @default.
• W1994678422 creator A5078300080 @default.
• W1994678422 creator A5082787613 @default.
• W1994678422 creator A5086877288 @default.
• W1994678422 creator A5090151288 @default.
• W1994678422 creator A5090711696 @default.
• W1994678422 creator A5091194689 @default.
• W1994678422 date "2015-04-17" @default.
• W1994678422 modified "2023-10-18" @default.
• W1994678422 title "Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI)" @default.
• W1994678422 cites W1531106656 @default.
• W1994678422 cites W180005029 @default.
• W1994678422 cites W1825602445 @default.
• W1994678422 cites W1964502734 @default.
• W1994678422 cites W1988629947 @default.
• W1994678422 cites W2007976642 @default.
• W1994678422 cites W2017413113 @default.
• W1994678422 cites W2026391423 @default.
• W1994678422 cites W2033169788 @default.
• W1994678422 cites W2047478437 @default.
• W1994678422 cites W2050700019 @default.
• W1994678422 cites W2055864845 @default.
• W1994678422 cites W2099683645 @default.
• W1994678422 cites W2111894088 @default.
• W1994678422 cites W2127526907 @default.
• W1994678422 cites W2127542144 @default.
• W1994678422 cites W2149687213 @default.
• W1994678422 cites W2150758178 @default.
• W1994678422 cites W2151342559 @default.
• W1994678422 cites W2152878178 @default.
• W1994678422 cites W2156058032 @default.
• W1994678422 cites W2156463034 @default.
• W1994678422 cites W2156916779 @default.
• W1994678422 cites W2163239734 @default.
• W1994678422 cites W2171344771 @default.
• W1994678422 cites W2340985467 @default.
• W1994678422 cites W4211158419 @default.
• W1994678422 cites W4239001479 @default.
• W1994678422 doi "https://doi.org/10.1186/s13063-015-0718-x" @default.
• W1994678422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4407416" @default.
• W1994678422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25902813" @default.
• W1994678422 hasPublicationYear "2015" @default.
• W1994678422 type Work @default.
• W1994678422 sameAs 1994678422 @default.
• W1994678422 citedByCount "25" @default.
• W1994678422 countsByYear W19946784222015 @default.
• W1994678422 countsByYear W19946784222016 @default.
• W1994678422 countsByYear W19946784222017 @default.
• W1994678422 countsByYear W19946784222018 @default.
• W1994678422 countsByYear W19946784222019 @default.
• W1994678422 countsByYear W19946784222020 @default.
• W1994678422 countsByYear W19946784222021 @default.
• W1994678422 countsByYear W19946784222022 @default.
• W1994678422 countsByYear W19946784222023 @default.
• W1994678422 crossrefType "journal-article" @default.
• W1994678422 hasAuthorship W1994678422A5003423056 @default.
• W1994678422 hasAuthorship W1994678422A5007115589 @default.
• W1994678422 hasAuthorship W1994678422A5014115470 @default.
• W1994678422 hasAuthorship W1994678422A5015168137 @default.
• W1994678422 hasAuthorship W1994678422A5020642212 @default.
• W1994678422 hasAuthorship W1994678422A5023154022 @default.
• W1994678422 hasAuthorship W1994678422A5024199696 @default.
• W1994678422 hasAuthorship W1994678422A5024835115 @default.
• W1994678422 hasAuthorship W1994678422A5025301409 @default.
• W1994678422 hasAuthorship W1994678422A5028936457 @default.
• W1994678422 hasAuthorship W1994678422A5029770659 @default.
• W1994678422 hasAuthorship W1994678422A5037820928 @default.
• W1994678422 hasAuthorship W1994678422A5042632008 @default.
• W1994678422 hasAuthorship W1994678422A5050403703 @default.
• W1994678422 hasAuthorship W1994678422A5050980807 @default.
• W1994678422 hasAuthorship W1994678422A5052636813 @default.
• W1994678422 hasAuthorship W1994678422A5053916099 @default.
• W1994678422 hasAuthorship W1994678422A5054873949 @default.

• next